Since he released his last album, “McCartney III,” at the end of 2020, Paul McCartney has not strayed far from the limelight. Besides tours of the Americas, Europe and Australia, he has made guest ...

No score yet, be the first to add. Balancing raucous guitar boogie and dreamy acoustic cuts, the 83-year-old legend shows off his considerable charm and impeccable songwriting chops on an unabashedly ...

Zackari Greif is a List Writer at DualShockers who has been covering games professionally since 2021. A lifelong gamer and former writer for GameRant and Fix Gaming Channel, Zackari has written across ...

Paul McCartney will turn 84 on June 18, so it's no wonder he's in a nostalgic and reflective mood on his 27th post-Beatles album, The Boys of Dungeon Lane. The title itself refers to an area of ...

Roll20 has unveiled a new free tool for Dungeons & Dragons players, as well as GMs of any fantasy title, as they have created the free Dungeon Generator. This is not AI or some poorly designed program ...

We've all been in a D&D session where the party has barrelled off the main path and into a cave or mine or crypt, despite the dungeon master's unsubtle hints that they've got absolutely nothing ...

If vanilla AI image generators leave you feeling underwhelmed, it's time to play with the spicy stuff. I put the most popular NSFW options to the test so you can find the one that really hits the mark ...

The live-action “Dungeon Crawler Carl” TV series is now officially in development at Peacock, Variety has learned. Based on the LitRPG book series of the same name by Matt Dinniman, the project was ...

Michael Ingram is a Senior Contributor from the United States of America. Michael has been writing for GameRant since 2021, writing both analytically and fiction for years beforehand. Michael is a ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

2025 felt very light on storytelling. Instead of launching new narratives, Wizards spent much of the year stabilizing the ecosystem around the revised rules. February’s Monster Manual completed the ...